Dr. Brendon Stiles, MD
Claim this profileStudies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
3 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage III
Stage II
Clinical Trials Brendon Stiles, MD is currently running
More about Brendon Stiles, MD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Brendon Stiles, MD has experience with
- Nivolumab
- Platinum Doublet
- Sub-ablative Stereotactic Body Radiation Therapy
Breakdown of trials Brendon Stiles, MD has run
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brendon Stiles, MD specialize in?
Brendon Stiles, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Brendon Stiles, MD currently recruiting for clinical trials?
Yes, Brendon Stiles, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Brendon Stiles, MD has studied deeply?
Yes, Brendon Stiles, MD has studied treatments such as Nivolumab, Platinum Doublet, Sub-ablative Stereotactic Body Radiation Therapy.
What is the best way to schedule an appointment with Brendon Stiles, MD?
Apply for one of the trials that Brendon Stiles, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.